Mostrar o rexistro simple do ítem

SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

dc.contributor.authorRueda Domínguez, A.
dc.contributor.authorCirauqui, B.
dc.contributor.authorGarcía Castaño, A.
dc.contributor.authorAlvarez Cabellos, R.
dc.contributor.authorCarral Maseda, A.
dc.contributor.authorCastelo Fernández, B.
dc.contributor.authorIglesias Rey, Leticia 
dc.contributor.authorRubió-Casadevall, J.
dc.contributor.authorArrazubi, V.
dc.contributor.authorMesía, R.
dc.date.accessioned2025-08-26T11:07:17Z
dc.date.available2025-08-26T11:07:17Z
dc.date.issued2022
dc.identifier.citationRueda Domínguez A, Cirauqui B, García Castaño A, Alvarez Cabellos R, Carral Maseda A, Castelo Fernández B, et al. SEOM-TTCC clinical guideline in nasopharynx cancer (2021). Clinical and Translational Oncology. 2022;24(4):670-80.
dc.identifier.issn1699-3055
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/64b4ef6b2107cd1e6d71d05e*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20851
dc.description.abstractNasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleSEOM-TTCC clinical guideline in nasopharynx cancer (2021)*
dc.typeArticleen
dc.authorsophosRueda Domínguez, R. A.
dc.authorsophosCirauqui, B.
dc.authorsophosGarcía Castaño, A.
dc.authorsophosAlvarez Cabellos, R.
dc.authorsophosCarral Maseda, A.
dc.authorsophosCastelo Fernández, B.
dc.authorsophosIglesias Rey, L.
dc.authorsophosRubió-Casadevall, J.
dc.authorsophosArrazubi, V.
dc.authorsophosMesía
dc.identifier.doi10.1007/s12094-022-02814-x
dc.identifier.sophos64b4ef6b2107cd1e6d71d05e
dc.issue.number4
dc.journal.titleClinical and Translational Oncology*
dc.page.initial670
dc.page.final680
dc.relation.publisherversionhttps://link.springer.com/content/pdf/10.1007%2Fs12094-022-02814-x.pdf;https://link.springer.com/content/pdf/10.1007/s12094-022-02814-x.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Ourensees
dc.subject.keywordHP Valdeorrases
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number24


Ficheiros no ítem

Descargar/
Nome:
971.pdf
Tamaño:
593.1Kb
Formato:
PDF
Descrición:
Rueda Domínguez A, Cirauqui B, García Castaño A, Alvarez Cabellos R, Carral Maseda ...

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Atribución 4.0 Internacional
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAtribución 4.0 Internacional